Singapore markets close in 2 hours
Straits Times Index
3,085.29 -25.44 (-0.82%) Nikkei
32,791.80 +483.94 (+1.50%) Hang Seng
16,172.52 -161.85 (-0.99%) FTSE 100
7,554.47 +40.75 (+0.54%) Bitcoin USD
42,134.41 -1,778.44 (-4.05%) CMC Crypto 200
868.61 -28.10 (-3.13%)
hVIVO plc (CRO.F)
Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
As of 08:05AM CET. Market open.
| Previous close | 0.2120 |
| Open | 0.2140 |
| Bid | 0.0000 x N/A |
| Ask | 0.0000 x N/A |
| Day's range | 0.2140 - 0.2140 |
| 52-week range | 0.0950 - 0.2440 |
| Volume | |
| Avg. volume | 0 |
| Market cap | 156.785M |
| Beta (5Y monthly) | 0.99 |
| PE ratio (TTM) | ∞ |
| EPS (TTM) | 0.0000 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 04 May 2023 |
| 1y target est | N/A |
- Reuters
hVIVO raises 2023 revenue view on demand for respiratory therapy testings
Drugmakers are in a race to develop vaccines and drugs to treat respiratory diseases caused by respiratory syncytial virus and COVID-19, resulting in increased demand for clinical testing of the products. The contract research organisation now expects its annual revenue to be 55 million pounds ($68.8 million), compared with 53 million pounds it previously expected.
© 2023 Yahoo. All rights reserved.